Medicine & Health - Pharmacy
Independent Plexaris and Cevaris testing shows positive and unique results
Exopharm is a world leader in the manufacture of exosome products.... more
Wednesday, February 12th, 2020 - Exopharm
New partnership to aid refugee healthcare professionals requalify
The only international English language test for healthcare professionals and a leading Australian refugee settlement service have joined forces to assist newly arrived professional refugees and asylum seekers requalify and contribute to Australia&rs... more
Wednesday, December 4th, 2019 - OET
Plexoval Exosome Wound Healing Human Study Starts
An important step forward for Exopharm: A clinical-stage company and world leader in exosome therapeutics for regenerative medicine.... more
Monday, August 26th, 2019 - Exopharm
Clinical stage Exopharm announces a successful Placement and the opening of a Share Purchase Plan
Melbourne, Australia: Exopharm Limited (ASX:EX1) has finalised a A$4.44 million share placement to new institutional and sophisticated investors. A further Share Purchase Plan (SPP) to existing shareholders has a target raise of A$2.7m.... more
Friday, July 26th, 2019 - Exopharm
Exopharm Secures Ethics Approval for the Plexoval Clinical Trial
Melbourne, Australia: Exopharm Limited (ASX:EX1) has received approval from Melbourne Health Human Research Ethics Committee to commence the PLEXOVAL wound healing study with its PlexarisTM product under the Australian Clinical Trials Notification (C... more
Monday, July 22nd, 2019 - Exopharm
The Next Big Thing in Regenerative Medicine: Exosomes
Stem cell therapy once seemed beguilingly simple. It was thought that by injecting additional stem cells into the body, the new cells would transform the way that we treat certain conditions. But nearly 20 years on, the general safety and efficacy of... more
Thursday, July 18th, 2019 - Exopharm
If you have concerns about skin cancer you must read this
Most skin cancers are a locally destructive cancerous growth of the skin. They originate from the cells of the outer layers of the skin (the epidermis) and unlike malignant melanoma, the vast majority of these sorts of skin cancers rarely s... more
Monday, July 15th, 2019 - Global Health Direct Pty Ltd
YOUR MIGRAINE OR YOUR ANXIETY - WHICH CAME FIRST? … AND HOW TO KEEP BOTH AT BAY
Migraine and anxiety often exist in a symbiotic relationship similar to the classic “chicken or the egg” dilemma. Which came first? Does anxiety trigger migraine, or does migraine cause anxiety?. According to the Anxiety and Depressi... more
Wednesday, May 15th, 2019 - Complimentary Healthcare Group
Could this protein explain why migraine is more common in women?
For reasons that scientists do not fully understand, women are three times more likely to experience migraine headaches than men. Now, new research into the activity of a protein could start to explain why.... more
Monday, April 22nd, 2019 - Complimentary Healthcare Group
Australian Research leads to global solution for treatment of Actinic Keratosis (AK Sunspots)
Actinic Keratosis (AK) is that scaly, red, and occasionally itchy patch of skin, resembling a mole, that usually appears on patients over 50 years old, but can manifest in younger adults particularly with prolonged sun exposure. The percentage risk o... more
Tuesday, April 9th, 2019 - Global Health Direct Pty Ltd